Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

被引:1103
|
作者
Lipinski, Christopher A. [1 ]
Lombardo, Franco [1 ]
Dominy, Beryl W. [1 ]
Feeney, Paul J. [1 ]
机构
[1] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
关键词
Rule of 5; Computational alert; Poor absorption or permeation; MWT; MLogP; H-Bond donors and acceptors; Turbidimetric solubility; Thermodynamic solubility; Solubility calculation; WATER PARTITION-COEFFICIENTS; AQUEOUS SOLUBILITY; ORGANIC-COMPOUNDS; THEORETICAL DESCRIPTORS; MELTING-POINT; OCTANOL; PARAMETER; CONSTRUCTION; ABSORPTION; PREDICTION;
D O I
10.1016/j.addr.2012.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP>4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (FITS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:4 / 17
页数:14
相关论文
共 50 条
  • [21] Computational and In Vitro ADME Approaches in Drug Discovery
    Waters, Nigel
    JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 891 - 891
  • [23] Computational approaches for innovative antiepileptic drug discovery
    Talevi, Alan
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (10) : 1001 - 1016
  • [24] Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development
    Hameed, Rabia
    Khan, Afsar
    Khan, Sehroon
    Perveen, Shagufta
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (05) : 592 - 598
  • [25] Recent advances in computational prediction of drug absorption and permeability in drug discovery
    Hou, Tingjun
    Wang, Junmei
    Zhang, Wei
    Wang, Wei
    Xu, Xiaojie
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (22) : 2653 - 2667
  • [26] Development of solubility screening methods in drug discovery
    Sugaya, Y
    Yoshiba, T
    Kajima, T
    Ishihama, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2002, 122 (03): : 237 - 246
  • [27] Bridging solubility between drug discovery and development
    Di, Li
    Fish, Paul V.
    Mano, Takashi
    DRUG DISCOVERY TODAY, 2012, 17 (9-10) : 486 - 495
  • [28] Proteomic approaches in drug discovery and development
    Soares, HD
    Williams, SA
    Snyder, PJ
    Gao, F
    Stiger, T
    Rohlff, C
    Herath, A
    Sunderland, T
    Putnam, K
    White, WF
    HUMAN BRAIN PROTEOME, 2004, 61 : 97 - +
  • [29] Integrated Computational Approaches and Tools for Allosteric Drug Discovery
    Amamuddy, Olivier Sheik
    Veldman, Wayde
    Manyumwa, Colleen
    Khairallah, Afrah
    Agajanian, Steve
    Oluyemi, Odeyemi
    Verkhivker, Gennady M.
    Bishop, Ozlem Tastan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [30] Recent Advances and Computational Approaches in Peptide Drug Discovery
    Maurya, Neha S.
    Kushwaha, Sandeep
    Mani, Ashutosh
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (31) : 3358 - 3366